.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Express Scripts
Citi
Novartis
Julphar
Federal Trade Commission
Deloitte
Fuji
McKinsey
Fish and Richardson

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017806

« Back to Dashboard

NDA 017806 describes THALLOUS CHLORIDE TL 201, which is a drug marketed by Bracco, Ge Healthcare, Lantheus Medcl, Mallinkrodt Nuclear, and Trace Life, and is included in six NDAs. It is available from three suppliers. Additional details are available on the THALLOUS CHLORIDE TL 201 profile page.

The generic ingredient in THALLOUS CHLORIDE TL 201 is thallous chloride tl-201. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the thallous chloride tl-201 profile page.

Summary for 017806

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 017806

Mechanism of ActionRadiopharmaceutical Activity

Suppliers and Packaging for NDA: 017806

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
THALLOUS CHLORIDE TL 201 thallous chloride tl-201 INJECTABLE;INJECTION 017806 NDA Lantheus Medical Imaging, Inc. 11994-427 11994-427-11 5.5 mL in 1 VIAL (11994-427-11)
THALLOUS CHLORIDE TL 201 thallous chloride tl-201 INJECTABLE;INJECTION 017806 NDA Lantheus Medical Imaging, Inc. 11994-427 11994-427-24 2.2 mL in 1 VIAL (11994-427-24)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1mCi/ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRAVENOUSStrength2mCi/ML
Approval Date:Oct 9, 1998TE:APRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
US Army
Citi
Covington
Healthtrust
Queensland Health
Chinese Patent Office
Cipla
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot